It started simply enough. I was watching Young Washington on Prime when it came out, and as a Marine Corps vet, I naturally found myself getting curious about the man behind the uniform—specifically, how he actually met his end. What began as a quick dive into 18th-century medical history quickly unraveled into something much bigger, mostly because I realized I wouldn't last two days back then without the internet. Let's be honest: the first day would be spent frantically trying to explain to an 18th-century blacksmith why my Wi-Fi router isn't working, and the second day would involve me dramatically perishing from sheer boredom long before any throat infection could get to me. But looking at how the first President of the United States was treated with leeches and bloodletting for a routine cold, it forces you to look at our own era through a completely different lens. It made me wonder: if medicine has evolved that drastically in just a couple of centuries, what does that mean for us today? And as artificial intelligence and biotechnology start rewriting the rules of human health, are we looking at a future where living to 120 is actually possible?
From George Washington to AI: Are We Entering an Era of 120-Year Lifespans?
If George Washington caught a severe throat infection today, he’d likely be given a dose of broad-spectrum antibiotics, spend a couple of days recovering in a hospital, and walk out completely fine.
Back in December 1799, however, standard medical practice involved draining roughly 40% of his blood to balance his "humors"—a treatment that tragically hastened his death at just 67 years old.
It makes you realize just how far modern medicine has come. But it also begs a bigger question: As technology and artificial intelligence accelerate, how long can humans actually expect to live? And what happens if someone blows past normal expectations all the way to 120?
The Historic Leap in Human Lifespan
For centuries, global life expectancy hovered stubbornly around 30 to 40 years. While adults could certainly live long lives, high infant mortality and fatal infectious diseases dragged the global average way down.
Thanks to the sanitation, vaccines, and antibiotics developed over the last 150 years, the global average life expectancy has climbed past 73, and individuals in developed nations frequently push into their 80s. If you're currently in your late 30s, statistical averages mean you can reasonably expect to see your late 70s or 80s.
The AI Wildcard: Can We Reach 120?
The absolute verified record for human longevity belongs to Jeanne Calment, who lived to be 122 years old (dying in 1997). Out of billions of people, she remains a rare statistical mountain peak.
For the rest of us, hitting 120 remains an extreme biological frontier. But artificial intelligence and biotechnology are completely changing the conversation.
Instead of just treating diseases one by one (like targeting a specific cancer), future longevity science aims to treat aging itself as a manageable problem:
AI-Driven Diagnostics: AI is speeding up drug discovery and catching chronic conditions years before symptoms show up.
Cellular Rejuvenation: Scientists are researching ways to clear out "zombie cells" that cause tissue damage and use [gene therapy] to repair cellular wear and tear.
Regenerative Medicine: Future [lab-grown organs] and advanced tissue engineering could mean [replacing worn-out parts before they fail].
Whether human biology has a hard cap or whether [AI-powered anti-aging tech] can push past it is the great debate of this century. But the margin between science fiction and science fact is shrinking fast.

data was created by google gemini.
Here is a comprehensive timeline graph stretching from the earliest reliable historical estimates (1540) all the way into future projections (2100).
It highlights key historical turning points, explaining the major drops and dramatic surges in human life expectancy over nearly six centuries.
Global Life Expectancy (1540–2100): History, Dips, and Future Projections
Key Historical Milestones, Dips, and Growth Drivers
The Pre-Modern Plateau (1540–1850):
Trend: For centuries, global life expectancy hovered stubbornly between 30 and 38 years.
Notable Dips: During the mid-17th century, dips occurred due to the peak of the Little Ice Age, which brought severe crop failures, widespread famines, and recurring waves of plague. High infant mortality and infectious diseases kept overall averages low.
The Early 20th-Century Setback (1900–1920):
Notable Dip: Global life expectancy temporarily dropped to around 32 years at the turn of the century. This dip was driven by the devastation of World War I combined with the catastrophic 1918 Influenza Pandemic (Spanish Flu), which wiped out tens of millions of young adults worldwide.
The Medical & Public Health Boom (1950–2000):
Massive Growth: Following World War II, life expectancy experienced the steepest vertical climb in human history, surging from roughly 46.5 years in 1950 to over 67 years by 2000.
Drivers: The commercialization of penicillin and antibiotics, widespread childhood vaccinations, the eradication of smallpox, and modern municipal water sanitation transformed public health.
The Present Era (2026):
Status: Global average life expectancy sits at approximately 73 to 74 years, with developed nations frequently pushing past 80 to 83 years.
The Future Horizon (2026–2100):
Projections: Driven by ongoing trends in biotechnology, preventative medicine, and AI-assisted drug discovery, UN and demographic models project global life expectancy to surpass 81 years by the end of the century, with individual health-spans pushing even further into uncharted territory.

WHO SHOULD WE BE WATCHING CLOSELY..
Here are the key companies driving the longevity and AI revolution alongside links directly to their homepages:
The longevity and life-extension revolution is being driven by heavy investments from tech giants, elite research institutions, and specialized biotech startups. These companies are transitioning medical science away from treating isolated diseases and moving toward reversing the fundamental biological hallmarks of aging using artificial intelligence, cellular reprogramming, and gene editing.
1. Altos Labs
What they do: Backed by massive multi-billion-dollar investments, Altos Labs is a premier biological and medical research enterprise focused on cellular rejuvenation programming. They research how to restore cell health and resilience using Yamanaka factors, with the ultimate goal of reversing disease and cellular aging.
Homepage URL: https://altoslabs.com
2. Insilico Medicine
What they do: Insilico is a pioneer in generative artificial intelligence for drug discovery. Utilizing its proprietary AI platform (Pharma.AI), the company designs novel therapeutic targets and drugs for age-related illnesses, pushing AI-discovered candidates rapidly through clinical validation.
Homepage URL: https://insilico.com
3. Calico Life Sciences (Calico Labs)
What they do: Founded as an independent research and development organization by Alphabet (Google's parent company), Calico focuses heavily on understanding the molecular biology that governs human lifespan and aging, using advanced computing and deep biological data analysis.
Homepage URL: https://www.calicolabs.com
4. Retro Biosciences
What they do: A prominent Silicon Valley startup aiming to add a decade of healthy human lifespan. Retro focuses on high-impact areas of regenerative biology, including cellular reprogramming, autophagy, and plasma therapeutics.
Homepage URL: https://www.retrobiosciences.com
5. BioAge Labs
What they do: BioAge uses a proprietary AI-driven discovery platform combined with human longitudinal data (omics) to map molecular pathways linked to aging. They develop therapeutic pipelines designed to target muscle loss, metabolic decline, and immune aging.
Homepage URL: https://bioagelabs.com
6. Life Biosciences
What they do: Life Biosciences is dedicated to targeting the core mechanisms of aging simultaneously. Their pipeline centers on cellular rejuvenation and clearing senescent ("zombie") cells that accumulate over time and drive chronic tissue inflammation.
Homepage URL: https://www.lifebiosciences.com
